logo
Fibrinogen concentrate for management of bleeding
Fibrinogen concentrate for management of bleeding
Factor XIII
Beware of being caught on the rebound
Clopidogrel discontinuation and platelet reactivity following coronary stenting
Plasma glutathione peroxidase in pediatric stroke families
A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
High platelet volume and increased risk of myocardial infarction
Thrombosis risk and survival in cancer patients with elevated C-reactive protein
Parental history and venous thromboembolism
Factor V Leiden as a risk factor for preterm birth - a population-based nested case-control study
Is extensive screening for cancer in idiopathic venous thromboembolism warranted?
Incidence of venous thromboembolism in Korea
Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis
Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults
Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance
Tissue factor pathway inhibitor and bacterial infection
Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
The prothrombin time/international normalized ratio (PT/INR) Line
An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance
TNF receptor-associated factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets
Platelet activation in hypertension associated with hypercholesterolemia
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease
An αIIb mutation in patients with Glanzmann thrombasthenia located in the N-terminus of blade 1 of the β-propeller (Asn2Asp) disrupts a calcium binding site in blade 6
Human C-reactive protein enhances thrombus formation after neointimal balloon injury in transgenic rabbits
CXCL4L1 inhibits angiogenesis and induces undirected endothelial cell migration without affecting endothelial cell proliferation and monocyte recruitment
Laboratory diagnosis of von Willebrand disease
Procoagulant myeloblast-derived microparticles in AML patients
The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients
Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels
Effect of provision of the NHS NPSA oral anticoagulant therapy patient information pack upon patients' knowledge and anticoagulant control
Thrombin generation is extremely sensitive to preheating conditions
Join ISTH